How much does keloid surgery cost?

Yes, for a small, stable, asymptomatic keloid that is not growing or causing distress, some people and clinicians reasonably choose ongoing observation over active treatment, since treatment itself carries its own time, cost and recurrence considerations.

Often, where the keloid causes genuine symptoms such as pain, itching or restricted movement, since this is then treatment of a medical condition. Purely cosmetic removal is less consistently funded. Confirm your specific entitlement first.

Because a keloid results from an overreacting wound-healing response, and a fresh surgical wound is, to the body, a new injury capable of triggering the same overreaction. Without an adjuvant measure to suppress that response, recurrence is common.

A recurrent keloid is frequently larger than the original, which is why adjuvant treatment is not optional in effective care. A recurrence typically needs a fresh episode of excision and a properly delivered adjuvant plan.

Most commonly steroid injections over several months, pressure therapy using a garment or device, or silicone sheeting, sometimes combined. Low-dose radiotherapy is reserved for higher-risk or recurrent keloids.

The excision itself travels well, but the months of adjuvant treatment that determine the outcome do not, unless a local clinician is specifically arranged, and briefed, before the excision to deliver and monitor that follow-up.

People of African, Caribbean and East Asian ancestry have a meaningfully higher risk than the general population. The earlobe and central chest are higher-risk sites for anyone, regardless of ancestry.

Typically several months, given at intervals of a few weeks, with your clinician assessing the scar’s response at each visit and adjusting the frequency or considering an additional measure if progress is limited.

The excision is usually done under local anaesthetic with manageable discomfort afterward. Steroid injections can cause brief stinging at the time of injection, generally well tolerated.

Yes, smaller or early keloids are sometimes managed with steroid injections, pressure or silicone alone, without excision, particularly where the risk of recurrence from surgery is judged to outweigh the benefit of removing the tissue.

Someone with specific experience treating keloids, not only general scar revision, who discusses an adjuvant plan as a core part of treatment from the first consultation rather than as an afterthought.

At the low doses used for keloids, it is generally considered safe and effective for higher-risk cases, though it carries a small, long-term theoretical risk that is weighed against the benefit of preventing recurrence.

Yes, this is one of the most common sites, often treated with excision plus a specific pressure clip device worn for months afterward, since the earlobe is a particularly high-risk site for recurrence.

Often within a few days for a small excision, though this depends on the site and size. Steroid injection visits during the adjuvant phase are brief and do not typically require time off.

Yes, itching, tenderness or pain are common keloid symptoms and, where present, often support a case for funded treatment, since these are genuine symptoms rather than a purely cosmetic concern.

Yes, if you are prone to keloid scarring, any new significant skin injury, including a minor surgical procedure elsewhere on the body, carries some risk of forming a new keloid at that site.

It is worth real scrutiny if it covers only the excision with no mention of adjuvant treatment, since this is the single factor most associated with a disappointing, and sometimes worse, outcome.

Yes, a larger keloid generally means a longer excision, a more extensive adjuvant plan, and sometimes a higher recurrence risk, all of which affect the total cost of the complete treatment plan.

Early use of silicone sheeting or pressure on a new wound in someone known to be prone to keloids can reduce, though not eliminate, the risk, which is worth discussing with a clinician before any planned surgery if you have a history of keloid scarring.

A hypertrophic scar stays within the boundary of the original wound and often improves over time on its own, while a keloid extends beyond that boundary and does not resolve without treatment, which is why the two are managed differently.

Details of any previous keloid treatment and its outcome, including whether excision alone was tried before, since a history of recurrence changes what adjuvant plan is likely to be recommended this time.

Yes, including after ear piercing, chickenpox scarring or vaccination sites, and the same principle applies: excision alone carries a high recurrence risk, so adjuvant treatment is recommended for children too, adapted to what a child can tolerate.

Rarely. Unlike an ordinary or hypertrophic scar, a keloid typically does not resolve on its own and tends to remain or slowly continue growing over years if left untreated, which is part of why most people eventually seek some form of treatment.

Sometimes, particularly to reduce redness and improve the texture of a keloid, often alongside rather than instead of the core treatments of excision, steroid injection, pressure or silicone, since laser alone does not reliably prevent regrowth.

Freezing the keloid tissue with liquid nitrogen, sometimes used alone for smaller keloids or combined with steroid injections, which some clinics offer as an alternative or addition to excision, particularly for smaller lesions.

This depends on the keloid’s site, size and your clinician’s judgement of which measure the tissue will respond to best. Many plans use both together rather than choosing one over the other.

Sometimes, where it makes sense clinically, but the adjuvant treatment that follows keloid excision still needs its own months-long plan regardless of what else was combined with the excision itself.

Yes, some scar is inevitable, since excision itself creates a new wound. The goal of adjuvant treatment is a flatter, less prominent scar than the original keloid, not a return to completely unmarked skin.

A clinician examines the scar for early thickening, redness or growth beyond its expected healed appearance, which is far easier to treat promptly with additional steroid injections than a regrowth that has been left unchecked for months.

No, a keloid is the body’s own overactive healing response to a wound, not an infection, though a genuinely infected wound can itself increase the risk of abnormal scarring, which is a separate issue your clinician would address.

Yes, keloid scarring tends to run in families, and a family history, alongside ancestry, is a further piece of information worth sharing with your clinician when discussing your personal recurrence risk and the intensity of adjuvant treatment needed.

Radiotherapy is typically a more specialised, and often more expensive, service than a course of steroid injections, which is part of why it is generally reserved for higher-risk or previously recurrent keloids rather than used as a first-line approach.

This is a decision made jointly with your clinician based on your specific recurrence risk, not simply a preference for convenience, since radiotherapy carries its own distinct risk profile that needs weighing against the benefit for your particular case.

Along lines that minimise tension on the healing wound where possible, since tension is a known contributor to abnormal scarring, though the keloid’s own size and site often limit how much choice there is.

Yes, particularly in people with a strong predisposition, and each site is generally assessed and treated individually, since risk and the right adjuvant approach can differ by location even in the same person.

Your clinician may extend the course, add pressure therapy or silicone, or, for an established keloid not responding adequately, discuss excision with a more intensive adjuvant plan built in from the outset.

A freshly healing scar is more prone to becoming darker if exposed to strong sun, so many clinicians recommend having excision and the early adjuvant phase during a period when you can reasonably keep the area covered or shaded, particularly for keloids on visible areas.

Yes, if a keloid recurs despite a first course of adjuvant treatment, a second round of excision with an intensified adjuvant plan, sometimes including radiotherapy where it was not used the first time, is a reasonable next step rather than an unusual one.

Success rates improve considerably compared with excision alone, though no combination eliminates recurrence risk entirely, which is why ongoing monitoring for at least a year remains part of a properly delivered plan regardless of which adjuvant method is used.

Yes, a larger keloid generally means a longer excision, more extensive pressure garments or a longer course of steroid injections, and a correspondingly higher total cost across the complete adjuvant plan than a small, early keloid would need.